{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:33:24Z","timestamp":1786980804037,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Grant R25 CA112383"],"award-info":[{"award-number":["Grant R25 CA112383"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012639","name":"METAvivor","doi-asserted-by":"publisher","award":["DK"],"award-info":[{"award-number":["DK"]}],"id":[{"id":"10.13039\/100012639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"crossref","award":["DK"],"award-info":[{"award-number":["DK"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10549-020-05864-3","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T09:28:46Z","timestamp":1599125326000},"page":"543-558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Risk factors for inflammatory and non-inflammatory breast cancer in North Africa"],"prefix":"10.1007","volume":"184","author":[{"given":"Catherine","family":"Schairer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hablas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim AbdelBar Seif","family":"Eldein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabab","family":"Gaafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henda","family":"Rais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Mezlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhat Ben","family":"Ayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wided Ben","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdellatif","family":"Benider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Tahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouna","family":"Khouchani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Aboulazm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Karkouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed El","family":"Bastawisy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Yehia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahinaz M.","family":"Gadalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia D.","family":"Merajver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda Morris","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7791-2698","authenticated-orcid":false,"given":"Ruth M.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr S.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"key":"5864_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3233\/BD-2006-22103","volume":"22","author":"WF Anderson","year":"2005","unstructured":"Anderson WF, Schairer C, Chen BE, Hance KW, Levine PH (2005) Epidemiology of inflammatory breast cancer (IBC). Breast Dis 22:9\u201323","journal-title":"Breast Dis"},{"key":"5864_CR2","doi-asserted-by":"publisher","first-page":"4754827","DOI":"10.1155\/2017\/4754827","volume":"2017","author":"RJ Morrow","year":"2017","unstructured":"Morrow RJ, Etemadi N, Yeo B, Ernst M (2017) Challenging a misnomer? The role of inflammatory pathways in inflammatory breast cancer. Med Inflamm 2017:4754827. https:\/\/doi.org\/10.1155\/2017\/4754827","journal-title":"Med Inflamm"},{"key":"5864_CR3","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/jnci\/dji172","volume":"97","author":"KW Hance","year":"2005","unstructured":"Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH (2005) Trends in inflammatory breast carcinoma incidence and survival: the Surveillance, Epidemiology and End Results program at the National Cancer Institute. J Natl Cancer Inst 97:966\u2013975","journal-title":"J Natl Cancer Inst"},{"key":"5864_CR4","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.ejca.2014.03.016","volume":"50","author":"M Corbex","year":"2014","unstructured":"Corbex M, Bouzbid S, Boffetta P (2014) Features of breast cancer in developing countries, examples from North-Africa. Eur J Cancer 50:1808\u20131818","journal-title":"Eur J Cancer"},{"key":"5864_CR5","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/jnci\/djt236","volume":"105","author":"L Amiri-Kordestani","year":"2013","unstructured":"Amiri-Kordestani L, Kamangar F, Zujewski JA (2013) Inflammatory breast cancer: yet another risk of the obesity epidemic? J Natl Cancer Inst 105:1340\u20131342","journal-title":"J Natl Cancer Inst"},{"key":"5864_CR6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S1470-2045(16)00064-4","volume":"17","author":"M Cristofanilli","year":"2016","unstructured":"Cristofanilli M (2016) Inflammatory breast cancer: a new approach. Lancet Oncol 17:544\u2013546","journal-title":"Lancet Oncol"},{"key":"5864_CR7","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/1097-0142(19801215)46:12<2741::AID-CNCR2820461234>3.0.CO;2-W","volume":"46","author":"N Mourali","year":"1980","unstructured":"Mourali N, Muenz L, Tabbane F, Belhassen S, Bahi J, Levine PH (1980) Epidemiologic features of rapidly progressing breast cancer in Tunisia. Cancer 46:2741\u20132746","journal-title":"Cancer"},{"key":"5864_CR8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02235745","volume":"6","author":"F Tabbane","year":"1985","unstructured":"Tabbane F, El May A, Hachiche M, Bahi J, Jaziri M, Cammoun M, Mourali N (1985) Breast cancer in women under 30 years of age. Breast Cancer Res Treat 6:137\u2013144","journal-title":"Breast Cancer Res Treat"},{"key":"5864_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.seminoncol.2007.11.017","volume":"35","author":"H Boussen","year":"2008","unstructured":"Boussen H, Bouzaiene H, Ben Hassouna J, Gamoudi A, Benna F, Rahal K (2008) Inflammatory breast cancer in Tunisia: reassessment of incidence and clinicopathological features. Semin Oncol 35:17\u201324","journal-title":"Semin Oncol"},{"issue":"suppl 11","key":"5864_CR10","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/cncr.25175","volume":"116","author":"H Boussen","year":"2010","unstructured":"Boussen H, Bouzaiene H, Ben Hassouna J, Dhiab T, Khomsi F, Benna F, Gamoudi A, Mourali N, Hechiche M, Rahal K, Levine PH (2010) Inflammatory breast cancer in Tunisia: epidemiologic and clinical trends. Cancer 116(suppl 11):2730\u20132735","journal-title":"Cancer"},{"key":"5864_CR11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.breast.2005.08.018","volume":"15","author":"MB L\u00ea","year":"2006","unstructured":"L\u00ea MB, Arriagada R, Bahi J, Pfeiffer F, Cammoun M, Tabbane F, Rubino C (2006) Are risk factors for breast cancer similar in women with inflammatory breast cancer and in those with non-inflammatory breast cancer? Breast 15:355\u2013362","journal-title":"Breast"},{"key":"5864_CR12","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1200\/JCO.1998.16.12.3731","volume":"16","author":"S Chang","year":"1998","unstructured":"Chang S, Buxdar AU, Hursting SD (1998) Inflammatory breast cancer and body mass index. J Clin Oncol 16:3731\u20133735","journal-title":"J Clin Oncol"},{"key":"5864_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12885-016-2369-z","volume":"16","author":"R Moslehi","year":"2016","unstructured":"Moslehi R, Freedman E, Zeinomar N, Veneroso C, Levine PH (2016) Importance of hereditary and selected environmental risk factors in the etiology of inflammatory breast cancer: a case-comparison study. BMC Cancer 16:334. https:\/\/doi.org\/10.1186\/s12885-016-2369-z","journal-title":"BMC Cancer"},{"key":"5864_CR14","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/jnci\/djt206","volume":"105","author":"C Schairer","year":"2013","unstructured":"Schairer C, Li Y, Frawley P, Graubard BI, Wellman RD, Buist DS, Kerlikowske K, Onega TL, Anderson WF, Miglioretti DL (2013) Risk factors for inflammatory breast cancer and other invasive breast cancers. J Natl Cancer Inst 105:1373\u20131384","journal-title":"J Natl Cancer Inst"},{"key":"5864_CR15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10552-015-0712-3","volume":"27","author":"RL Atkinson","year":"2016","unstructured":"Atkinson RL, El-Zein R, Valero V, Lucci A, Bevers TB, Fouad T, Liao W, Ueno NT, Woodward WA, Brewster AM (2016) Epidemiological risk factors associated with inflammatory breast cancer subtypes. Cancer Causes Control 27:359\u2013366","journal-title":"Cancer Causes Control"},{"key":"5864_CR16","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1158\/1055-9965.EPI-16-0647","volume":"26","author":"C Schairer","year":"2017","unstructured":"Schairer C, Gadalla SM, Pfeiffer RM, Moore SC, Engels EA (2017) Diabetes, abnormal glucose, dyslipidemia, hypertension, and risk of inflammatory and other breast cancer. Cancer Epidemiol Biomarkers Prev 26:862\u2013868","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5864_CR17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1158\/1055-9965.EPI-11-0833","volume":"21","author":"JA Schlichting","year":"2012","unstructured":"Schlichting JA, Soliman AS, Schairer C, Banerjee M, Rozek LS, Schottenfeld D, Harford JB, Merajver SD (2012) Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000\u20132007. Cancer Epidemiol Biomarkers Prev 21:155\u2013165","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5864_CR18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/ijerph14040404","volume":"14","author":"L Scott","year":"2017","unstructured":"Scott L, Mobley LR, Il\u2019yasova D (2017) Geospatial analysis of inflammatory breast cancer and associated community characteristics in the United States. Int J Environ Res Public Health 14:404","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"5864_CR19","doi-asserted-by":"publisher","first-page":"e0191333","DOI":"10.1371\/journal.pone.0191333","volume":"13","author":"M Khalis","year":"2018","unstructured":"Khalis M, Charbotel B, Chaj\u00e8s V, Rinaldi S, Moskal A, Biessy C, Dossus L, Huybrechts I, Fort E, Mellas N, Elfakir S, Charaka H, Nejjari C, Romieu I, El Rhazi K (2018) Menstrual and reproductive factors and risk of breast cancer: a case\u2013control study in the Fez region, Morocca. PLoS ONE 13(1):e0191333. https:\/\/doi.org\/10.1371\/journal.pone.0191333","journal-title":"PLoS ONE"},{"key":"5864_CR20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s12032-013-0480-4","volume":"30","author":"M Awatef","year":"2013","unstructured":"Awatef M, Olfa G, Slim BA (2013) Impact of menstrual and reproductive factors on breast cancer risk in Tunisia: a case\u2013control study. Med Oncol 30:480","journal-title":"Med Oncol"},{"key":"5864_CR21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10552-009-9471-3","volume":"21","author":"M Awatef","year":"2010","unstructured":"Awatef M, Olfa G, Imed H, Kacem M, Imen C, Rim C, Mohamed B, Slim BA (2010) Breastfeeding reduces breast cancer risk: a case\u2013control study in Tunisia. Cancer Causes Control 21:393\u2013397","journal-title":"Cancer Causes Control"},{"key":"5864_CR22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/cam4.36","volume":"1","author":"AS Soliman","year":"2012","unstructured":"Soliman AS, Schairer C (2012) Considerations in setting up and conducting epidemiologic studies of cancer in middle- and low-income countries: the experience of a case-control study of inflammatory breast cancer in North Africa in the past 10 years. Cancer Med 1:338\u2013349","journal-title":"Cancer Med"},{"key":"5864_CR23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10549-019-05237-5","volume":"176","author":"C Schairer","year":"2019","unstructured":"Schairer C, Hablas A, Seif Eldein IAS, Gaafar R, Rais H, Mezlini A, Ayed FB, Ayoub WB, Benider A, Tahri A, Khouchani M, Aboulazm D, Karkouri M, Eissa S, Pfeiffer RM, Gadalla SM, Swain SM, Merajver SD, Brown LM, Soliman AS (2019) Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa. Breast Cancer Res Treat 176:407\u2013417","journal-title":"Breast Cancer Res Treat"},{"key":"5864_CR24","first-page":"85","volume":"27","author":"TE Raghunathan","year":"2001","unstructured":"Raghunathan TE, Lepowski JM, van Hoewyk M, Solenberger P (2001) A multivariate technique for multiply imputing missing values using a sequence of regression models. Survey Methodol 27:85\u201395","journal-title":"Survey Methodol"},{"key":"5864_CR25","first-page":"829","volume":"83","author":"SV Subramanian","year":"2005","unstructured":"Subramanian SV, Nandy S, Irving M, Gordon D, Davey Smith G (2005) Role of socioeconomic markers and state prohibition policy in predicting alcohol consumption among men and women in India: a multilevel statistical analysis. Bull World Health Organ 83:829\u2013836","journal-title":"Bull World Health Organ"},{"key":"5864_CR26","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/(SICI)1097-0215(19970904)72:5<720::AID-IJC3>3.0.CO;2-U","volume":"72","author":"P Bonnier","year":"1997","unstructured":"Bonnier P, Romain S, Dilhuydy JM, Bonichon F, Julien JP, Charpin C, Lejeune C, Martin PM, Piana L (1997) Influence of pregnancy on the outcome of breast cancer: a case\u2013control study. Int J Cancer 72:720\u2013727","journal-title":"Int J Cancer"},{"key":"5864_CR27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/M18-1323","volume":"170","author":"HB Nichols","year":"2019","unstructured":"Nichols HB, Schoemaker MJ, Cai J, Xu J, Wright LB, Brook MN, Jones ME, Adami HO, Baglietto L, Bertrand KA, Blot WJ, Boutron-Ruault MC, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Gram IT, Hankinson SE, Hoffman-Bolton J, Kaaks R, Key TJ, Kitahara CM, Larsson SC, Linet M, Merritt MA, Milne RL, Pala V, Palmer JR, Peeters PH, Riboli E, Sund M, Tamimi RM, Tj\u00f8nneland A, Trichopoulou A, Ursin G, Vatten L, Visvanathan K, Weiderpass E, Wolk A, Zheng W, Weinberg CR, Swerdlow AJ, Sandler DP (2019) Breast cancer risk after recent childbirth: a pooled analysis of 15 prospective studies. Ann Intern Med 170:22\u201330","journal-title":"Ann Intern Med"},{"issue":"12","key":"5864_CR28","doi-asserted-by":"crossref","first-page":"e51446","DOI":"10.1371\/journal.pone.0051446","volume":"7","author":"Z Cheraghi","year":"2012","unstructured":"Cheraghi Z, Poorolajal J, Hashem T, Esmailnasab N, Doosti Irani A (2012) Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS ONE 7(12):e51446","journal-title":"PLoS ONE"},{"key":"5864_CR29","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/bjs.9229","volume":"100","author":"KM De Bruijn","year":"2013","unstructured":"De Bruijn KM, Arends LR, Hansen BE, Leeflang S, Ruiter R, van Eijck CH (2013) Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer. Br J Surg 100:1421\u20131429","journal-title":"Br J Surg"},{"issue":"3","key":"5864_CR30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.canep.2011.02.009","volume":"35","author":"AC Klassen","year":"2011","unstructured":"Klassen AC, Smith KC (2011) The enduring and evolving relationship between social class and breast cancer burden: A review of the literature. Cancer Epidemiol 35(3):217\u2013234","journal-title":"Cancer Epidemiol"},{"key":"5864_CR31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00008469-200206000-00014","volume":"11","author":"JE Rigby","year":"2002","unstructured":"Rigby JE, Morris JA, Lavelle J, Stewart M, Gatrell AC (2002) Can physical trauma cause breast cancer? Eur J Cancer Prev 11:307\u2013311","journal-title":"Eur J Cancer Prev"},{"key":"5864_CR32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/EDE.0b013e3181adbb1e","volume":"20","author":"M Lambe","year":"2009","unstructured":"Lambe M, Johansson ALV, Altman D, Eloranta S (2009) Mastitis and the risk of breast cancer. Epidemiology 20:747\u2013751","journal-title":"Epidemiology"},{"key":"5864_CR33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/bfm.2014.0141","volume":"10","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Chen J, Li Q, Huang W, Lan H, Jiang H (2015) Association between breastfeeding and breast cancer risk: evidence from a meta-analysis. Breastfeed Med 10:175\u2013182","journal-title":"Breastfeed Med"},{"key":"5864_CR34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10549-005-9015-9","volume":"95","author":"SJ Van Laere","year":"2006","unstructured":"Van Laere SJ, Van den Eynden GG, Van der Auwera I, Vandenberghe M, van Dam P, Van Marck EA, van Golen KL, Vermeulen PB, Dirix LY (2006) Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling. Breast Cancer Res Treat 95:234\u2013255","journal-title":"Breast Cancer Res Treat"},{"issue":"15","key":"5864_CR35","doi-asserted-by":"publisher","first-page":"e568","DOI":"10.1016\/S1470-2045(15)00146-1","volume":"16","author":"WA Woodward","year":"2015","unstructured":"Woodward WA (2015) Inflammatory breast cancer: unique biological and therapeutic considerations. Lancet Oncol 16(15):e568\u2013e576. https:\/\/doi.org\/10.1016\/S1470-2045(15)00146-1","journal-title":"Lancet Oncol"},{"key":"5864_CR36","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1038\/sj.onc.1205389","volume":"21","author":"ML Alpaugh","year":"2002","unstructured":"Alpaugh ML, Tomlinson JS, Kasraeian S, Barsky SH (2002) Cooperative role of E-cadherin and sialyl-Lewis X\/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma. Oncogene 21:3631\u20133643","journal-title":"Oncogene"},{"issue":"suppl 11","key":"5864_CR37","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1002\/cncr.25169","volume":"116","author":"PB Vermeulen","year":"2010","unstructured":"Vermeulen PB, van Golen KL, Dirix LY (2010) Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of current knowledge. Cancer 116(suppl 11):2748\u20132754","journal-title":"Cancer"},{"key":"5864_CR38","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1158\/1078-0432.CCR-05-1142","volume":"11","author":"I Van der Auwera","year":"2005","unstructured":"Van der Auwera I, Van den Eynden GG, Colpaert CG, Van Laere SJ, van Dam P, Van Marck EA, Dirix LY, Vermeulen PB (2005) Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clin Cancer Res 11:7637\u20137642","journal-title":"Clin Cancer Res"},{"key":"5864_CR39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/bcr89","volume":"2","author":"CG Kleer","year":"2000","unstructured":"Kleer CG, van Golen KL, Merajver SD (2000) Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants. Breast Cancer Res 2:423\u2013429","journal-title":"Breast Cancer Res"},{"key":"5864_CR40","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1158\/1078-0432.CCR-06-2416","volume":"13","author":"LS Angelo","year":"2007","unstructured":"Angelo LS, Kurzrock (2007) Vascular endothelial growth factor and its relationship to inflammatory mediators. Clin Cancer Res 13:2825\u20132830","journal-title":"Clin Cancer Res"},{"key":"5864_CR41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.coph.2016.07.005","volume":"29","author":"R Kolb","year":"2016","unstructured":"Kolb R, Sutterwala FS, Weizhou Z (2016) Obesity and cancer: inflammation bridges the two. Curr Opin Pharmacol 29:77\u201389","journal-title":"Curr Opin Pharmacol"},{"key":"5864_CR42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98\u2013107","journal-title":"Nat Rev Immunol"},{"key":"5864_CR43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.breast.2017.07.008","volume":"35","author":"R Ruiz","year":"2017","unstructured":"Ruiz R, Herrero C, Strasser-Weippl K, Touya D, St Louis J, Bukowski A, Goss PE (2017) Epidemiology and pathophysiology of pregnancy-associated breast cancer: a review. Breast 35:136\u2013141","journal-title":"Breast"},{"key":"5864_CR44","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","volume":"9","author":"L Chen","year":"2017","unstructured":"Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L (2017) Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9:7204\u20137218","journal-title":"Oncotarget"},{"key":"5864_CR45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/cyto.2002.1032","volume":"18","author":"S Nishimura","year":"2002","unstructured":"Nishimura S, Maeno N, Matsuo K, Nakajima T, Kitajima I, Saito H, Maruyama I (2002) Human lactiferous mammary gland cells produce vascular endothelial growth factor (VEGF) and express the VEGF receptors, Flt-1 and KDR\/Flk-1. Cytokine 18:191\u2013198","journal-title":"Cytokine"},{"key":"5864_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-014-2852-7","volume":"144","author":"KN Anderson","year":"2014","unstructured":"Anderson KN, Schwab RB, Martinez ME (2014) Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat 144:1\u201310","journal-title":"Breast Cancer Res Treat"},{"key":"5864_CR47","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ijc.23943","volume":"124","author":"R Suzuki","year":"2009","unstructured":"Suzuki R, Orsini N, Saji S, Key TJ, Wolk A (2009) Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status: a meta-analysis. Int J Cancer 124:698\u2013712","journal-title":"Int J Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05864-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-020-05864-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05864-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:12:42Z","timestamp":1630527162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-020-05864-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["5864"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05864-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,2]]},"assertion":[{"value":"24 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Sandra Swain reports receiving honoraria from Novartis, personal fees from Cardinal Health, Daiichi-Sankyo, Eli Lilly & Co., Genentech\/Roche, Genomic Health, Inivata, Peiris Pharmaceuticals, Tocagen; research support from Genentech; travel and accommodations from Caris Centers of Excellence, Daiichi-Sankyo, Eli Lilly & Co., Genentech\/Roche, NanoString Technologies; and remuneration from AstraZeneca for participation on OlympiA IDMC. The other authors declare they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committees.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all study participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}